🧬 Genetic Testing & Biomarkers: Personalized Treatment Insights

Modern mesothelioma treatment is moving toward personalized medicine — care tailored to your tumor’s unique biology.
Genetic testing and biomarker analysis help doctors understand what drives your cancer and select therapies that work best for you.

📞 Need help understanding your test results or finding a clinical trial? Call 800.291.0963 today.

🔍 Step 1: What Genetic Testing and Biomarkers Are

Genetic testing examines changes (mutations) in tumor DNA that may influence how the cancer grows.
Biomarkers are measurable molecules — proteins, genes, or receptors — that tell doctors how your body or tumor responds to treatment.

Together, they help doctors:

• 🧫 Identify tumor subtypes and behavior.

• 🎯 Match patients with targeted or immunotherapy drugs.

• ⚕️ Monitor treatment response or resistance.

• 🧠 Predict which therapies are most likely to succeed.

💡 These insights turn “one-size-fits-all” care into precision treatment designed for your tumor.

🧪 Step 2: How Testing Is Done

Genetic and biomarker testing usually starts with your biopsy or surgical tissue sample.
Specialized laboratories analyze this material using molecular sequencing or immunohistochemistry (IHC).

Common tests include:

• 🔬 Next-Generation Sequencing (NGS): Finds mutations like BAP1, NF2, or TP53 linked to mesothelioma.

• 🧫 IHC Marker Tests: Check proteins such as calretinin, WT-1, and D2-40 to confirm mesothelioma type.

• 💉 Blood-Based Biomarkers: Measures circulating DNA or proteins like mesothelin (SMRP) and fibulin-3.

🧠 Testing can be performed at diagnosis or later to monitor how your tumor changes over time.

⚖️ Step 3: Why Genetic Insights Matter

Results from genetic testing can dramatically change your care plan.

They can reveal:

• 💊 Targetable mutations that respond to specific drugs.

• 🌈 Eligibility for clinical trials involving immunotherapy or gene-directed treatments.

• 🧬 Family risk factors for inherited mutations.

• 🩺 Prognostic clues that predict survival and treatment response.

📈 Patients with actionable mutations may benefit from therapies unavailable just a few years ago.

💊 Step 4: Biomarkers That Shape Mesothelioma Treatment

🔬 These biomarkers are reshaping how mesothelioma is classified and treated worldwide.

📈 Step 5: How Results Affect Treatment Options

After your test results return, your oncologist and pathologist meet to design a personalized plan:

• 🧪 Combine targeted drugs with chemotherapy or immunotherapy.

• 🧬 Identify clinical trials focused on your tumor’s mutation profile.

• 💊 Adjust doses or switch therapies based on response markers.

• 🧾 Update prognosis using real data from similar genetic cases.

💡 The more your care is customized, the higher your chances for control and extended survival.

🗓️ Step 6: When to Request Testing

You can request testing at several points:

• 📅 Immediately after diagnosis, to guide first-line therapy.

• 🔄 Before changing treatment, to see if the tumor evolved.

• 🧫 When entering a clinical trial, as many require biomarker matching.

✅ Ask your doctor or treatment center:

• “Has my tumor been tested for biomarkers or mutations?”

• “Can I get a copy of my genomic report?”

• “Are there any clinical trials based on my results?”

📞 Where to Get Help

If you’ve been diagnosed with mesothelioma and want to understand your test results or explore genetic-based treatments, our advocates can help.
We’ll connect you to top testing centers, clinical trials, and mesothelioma specialists.

👉 Call 800.291.0963 to learn more about your personalized treatment options.

🧾 Summary

Genetic testing and biomarkers are transforming mesothelioma care.
They uncover crucial details about your tumor’s DNA, helping doctors design a treatment plan that’s unique to you.

The future of mesothelioma treatment is personal — and it starts with your genes.
📞 Call 800.291.0963 today to take the next step.